☆ 4.4 Article

Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: An analysis of cost-utility and clinical outcomes

WORLD ALLERGY ORGANIZATION JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Article Allergy

Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors

Xiangdong Wang et al.

Summary: This study aimed to identify the endotypes of patients with chronic rhinosinusitis (CRS) based on inflammatory and remodeling factors. The findings suggest that diverse inflammatory mechanisms result in distinct CRS endotypes and remodeling profiles, providing guidance for targeted treatment decisions.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Review Immunology

Precision medicine in chronic rhinosinusitis - using endotype and endotype-driven therapeutic options

Yutong Sima et al.

Summary: This review summarizes and discusses the mechanisms and endotypes of chronic rhinosinusitis. Inflammatory cells and the microbiome play important roles in the pathophysiology of the disease. The review also lists potential biomarkers and provides advice on clinical management and treatment options for patients with different endotypes.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Add to Collection

Editorial Material Allergy

Knowledge gaps in using type 2 biologics for real-world treatment of chronic rhinosinusitis with nasal polyps

Hongfei Lou et al.

ALLERGY (2022)

Add to Collection

Article Allergy

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert et al.

Summary: This study confirms the sustained efficacy and safety of omalizumab treatment for chronic rhinosinusitis with nasal polyps for up to one year, which is of significant importance for patients who do not respond to nasal corticosteroids.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Editorial Material Allergy

Chronic rhinosinusitis: Future treatments and unmet needs

Sneha Giri et al.

Summary: Chronic rhinosinusitis is a common inflammatory disease characterized by two major phenotypes: CRS with nasal polyps and CRS without nasal polyps. Research indicates that 80-90% of patients with CRSwNP belong to the type 2 endotype, while 30-50% of patients with CRSsNP have severe disease requiring endoscopic sinus surgery.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Review Allergy

Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era

Joaquim Mullol et al.

Summary: This review summarizes the clinical evidence on quality of life outcomes with current treatments for CRSwNP up to 2021, and assesses the improvement in QoL after biologic treatments, especially for patients with reported comorbidities in interventional studies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Article Allergy

Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers - A real-life prospective study

Ming Zheng et al.

Summary: The beneficial effectiveness of omalizumab in difficult-to-treat CRSwNP and asthma patients was confirmed. ECRSwNP and male patients were more likely to have positive responses. Multiple cutoff values for LMS and ACT may serve as useful predictors for improvement in difficult-to-treat CRSwNP patients.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Add to Collection

Article Medicine, Research & Experimental

Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps

George A. Scangas et al.

Summary: The study compared the cost-effectiveness of dupilumab and ESS in treating CRSwNP, with the results showing that the ESS treatment strategy is more cost-effective. Further research is needed to identify potential phenotypes or endotypes that will benefit most from dupilumab treatment in a cost-effective manner.

LARYNGOSCOPE (2021)

Add to Collection

Article Allergy

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

Claus Bachert et al.

Summary: Uncontrolled severe CRSwNP can be challenging due to its association with asthma, NSAID-exacerbated respiratory disease, and allergies. The European Forum proposes structured definitions to facilitate communication among clinicians and offers a practical algorithm for defining type 2 inflammation in CRSwNP. Suggestions for evaluating treatment options, including surgery and biologics, are provided to inform patients for decision-making processes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Review Allergy

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

Ioana Agache et al.

Summary: This systematic review found that Dupilumab, Omalizumab, and Mepolizumab have some evidence supporting their efficacy and safety for patients with CRSwNP, reducing the need for surgery or oral corticosteroid use, and improving smell and quality of life.

ALLERGY (2021)

Add to Collection

Review Allergy

Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps

Claus Bachert et al.

Summary: CRSwNP is a disease with type 2 inflammation that greatly impacts patients' quality of life with severe symptoms. Existing treatments may lead to recurrence of nasal polyps and adverse effects, particularly in patients with comorbid conditions like asthma and nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. New therapies targeting type 2 inflammatory disease pathophysiology are needed to effectively control symptoms and minimize recurrence.

JOURNAL OF ASTHMA AND ALLERGY (2021)

Add to Collection

Article Allergy

Changes in Clinical and Histological Characteristics of Nasal Polyps in Northern China over the Past 2-3 Decades

Jiaqi Yu et al.

Summary: The study found that the comorbidity of asthma significantly increased in CRSwNP patients in Northern China over the past 2-3 decades, and the cellular phenotype of CRSwNP has changed, with an increase in eosinophil-dominant CRSwNP. The rate of polyp recurrence increased in CRSwNP patients, but not in eosinophilic CRSwNP. Smoking and age did not significantly impact the inflammatory patterns of CRSwNP.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)

Add to Collection

Article Allergy

What is the contribution of IgE to nasal polyposis?

Claus Bachert et al.

Summary: Nasal tissue of nasal polyp patients shows elevated polyclonal IgE with proinflammatory properties, possibly induced by Staphylococcus aureus enterotoxins acting as superantigens. Omalizumab targets T2 inflammation by blocking IgE, reducing nasal polyp score and improving symptoms.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

Joseph K. Han et al.

Summary: The study aimed to evaluate the efficacy and safety of mepolizumab in adults with recurrent, refractory severe bilateral chronic rhinosinusitis with nasal polyps. Results showed that mepolizumab treatment significantly improved nasal polyp size and nasal obstruction symptoms, with fewer adverse events.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Review Allergy

Biologics for chronic rhinosinusitis with nasal polyps

Claus Bachert et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Editorial Material Allergy

The sense of smell in chronic rhinosinusitis

Joaquim Mullol et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Adult chronic rhinosinusitis

Claus Bachert et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Add to Collection

Review Medicine, Research & Experimental

Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases

Ioana Agache et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Medicine, Research & Experimental

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps

Neil Bhattacharyya et al.

LARYNGOSCOPE (2019)

Add to Collection

Article Allergy

Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis

Whitney W. Stevens et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert et al.

LANCET (2019)

Add to Collection

Review Medicine, Research & Experimental

Recovery of olfaction after sinus surgery for chronic rhinosinusitis: A review

Boris R. Haxel

LARYNGOSCOPE (2019)

Add to Collection

Article Otorhinolaryngology

Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years

Weiqing Wang et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis

Naweed I. Chowdhury et al.

LARYNGOSCOPE (2018)

Add to Collection

Review Allergy

Endotype-driven care pathways in patients with chronic rhinosinusitis

Claus Bachert et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Review Immunology

Chronic rhinosinusitis: the rationale for current treatments

Nsangou Ghogomu et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)

Add to Collection

Article Allergy

Chronic rhinosinusitis in Asia

Yuan Zhang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Add to Collection

Review Allergy

Economics of Chronic Rhinosinusitis

Luke Rudmik

CURRENT ALLERGY AND ASTHMA REPORTS (2017)

Add to Collection

Article Allergy

An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011

X. D. Wang et al.

ALLERGY (2016)

Add to Collection

Review Clinical Neurology

Anesthesia and cognitive disorders: a systematic review of the clinical evidence

Federico Bilotta et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Add to Collection

Article Allergy

Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania

Xiangdong Wang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers

Peter Tomassen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Review Clinical Neurology

Anesthesia and cognitive disorders: a systematic review of the clinical evidence

Federico Bilotta et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Add to Collection

Article Medicine, Research & Experimental

Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis

James G. Krings et al.

LARYNGOSCOPE (2014)

Add to Collection

Article Otorhinolaryngology

SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis

Adam S. DeConde et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)

Add to Collection

Article Otorhinolaryngology

Response Shift in Quality of Life After Endoscopic Sinus Surgery for Chronic Rhinosinusitis

Adam S. DeConde et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)

Add to Collection

Article Allergy

ICON: chronic rhinosinusitis

Claus Bachert et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2014)

Add to Collection

Article Allergy

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

Philippe Gevaert et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.